Pharvaris (PHVS) Net Cash Flow (QoQ) (2020 - 2026)
Pharvaris (PHVS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.46% |
| Dec 31, 2025 | -128.92% |
| Sep 30, 2025 | 546.86% |
| Jun 30, 2025 | 16.63% |
| Mar 31, 2025 | -10.29% |
| Dec 31, 2024 | -3.19% |
| Sep 30, 2024 | -21.25% |
| Jun 30, 2024 | -15.74% |
| Mar 31, 2024 | -109.96% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | -199.97% |
| Jun 30, 2023 | 72,405,958.79% |
| Mar 31, 2023 | -29.13% |
| Dec 31, 2022 | -36.71% |
| Sep 30, 2022 | -201.54% |
| Jun 30, 2022 | 74.79% |
| Mar 31, 2022 | -34.01% |
| Dec 31, 2021 | -26.93% |
| Sep 30, 2021 | 14.74% |
| Jun 30, 2021 | -108.64% |